Stay updated on Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision label changed from v3.3.3 to v3.3.4, a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:00:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with New York as a site; the old New York Locations header was removed and the page updated to revision v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:42:45.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:21:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice. All study details, locations, and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:45:40.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant changes detected between the previous and current page versions. The content and study details appear unchanged aside from minor layout tweaks.
    Difference
    0.4%
    Check dated 2025-11-03T20:34:46.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T04:51:01.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in Pancreatic Cancer Clinical Trial page.